Trial intelligence / Profile preview

MANDALA: PT027 (Airsupra) vs Albuterol in Asthma

NCT03769090Phase 3Completed

Sponsor
Bond Avillion 2 Development LP
Start
Dec 2018
Primary completion
Aug 2021
Modality
Orthosteric Ligands
Countries
11
01

Overview

A Phase 3 trial of salbutamol + budesonide in asthma, sponsored by Bond Avillion 2 Development LP. Started Dec 2018; status: completed.

02

Drugs

salbutamol + budesonide
03

Conditions

asthma

Beyond the preview

Go deeper on NCT03769090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03769090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call